Bright Minds Biosciences Inc. (DRUG)
Nasdaq: DRUG · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2020
Who owns Bright Minds Biosciences Inc.
As filed with the SECHolders of 5% or more
5
Ian McDonald holds 13.7% of COMMON STOCK, WITHOUT PAR VALUE, as its SCHEDULE 13D/A filed Jul 2, 2026 says.
Directors and officers
0
report now, of 0 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Ian McDonald
SCHEDULE 13D/A · filed Jul 2, 2026 · COMMON STOCK, WITHOUT PAR VALUE
Janus Henderson Group PLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock · 13.1% in May 15, 2026
Cormorant Asset Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Shares · 9.71% in Apr 30, 2026
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13G/A · filed May 12, 2026 · Common Stock, no par value · 6.4% in Nov 14, 2025
Vestal Point Capital, LP
SCHEDULE 13G · filed May 15, 2026 · Common Shares, no par value
Perceptive Advisors LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Shares, without par value · reported falling below 5%, from 6.3% in May 15, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Shares, no par value · reported falling below 5%, from 5.58% in Nov 13, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Shares, without par value · reported falling below 5%
RA Capital Management, L.P.
SCHEDULE 13G/A · filed May 15, 2025 · Common Shares · reported falling below 5%
Sio Capital Management, LLC
SCHEDULE 13G/A · filed Nov 12, 2025 · Common Shares · reported falling below 5%, from 7.27% in Aug 13, 2025
Commodore Capital LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Shares, without par value · reported falling below 5%, from 7.2% in Feb 14, 2025
What DRUG reports owning in othersstakes of 5% or more, and other ties
Bright Minds Biosciences Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window1 of 3 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% owner | 1 | $9.8M | 0 | 0 | $0 |